Tramadol ampoules or vials for IV, IM and SC administration and preservative-free solutions for injection by the various spinal routes (epidural, intrathecal, caudal, etc.) are available forms in these regions. Tramadol formulations approved in several countries include, tablets, capsules, effervescent powders.
Continuous infusion versus repetitive bolus. The analgesic effect of continuous infusion of tramadol was compared to repeated bolus administration in 135 patients undergoing abdominal surgery (Rud U, Fischer MV, Mewes R, Paravcini D., " Postoperative Analgesie mit Tramadol Kontinuierliche Infusion versus repetitive" (Postoperative analgesia with tramadol.
Total tramadol consumption, however, was about 30% higher in the infusion group (p<0.05) and was associated with and increased incidence of minor adverse events.
Excretion: The principal route of elimination of ketorolac and its metabolites is renal. About 92% of a given dose is found in the urine, approximay 40% as metabolites and 60% as unchanged ketorolac. Approximay 6% of a dose is excreted in the feces. A single-dose study with 10 mg TORADOL (n=9) demonstrated that.
·TORADOL is CONTRAINDICATED in patients currently receiving ASA or NSAIDs because of the cumulative risk of inducing serious NSAID-related side effects. DOSAGE AND ADMINISTRATION TORADOL ORAL.
·Hypersensitivity reactions, ranging from bronchospasm to anaphylactic shock, have occurred and appropriate counteractive measures must be available when administering the first dose of TORADOL IV/IM (see CONTRAINDICATIONS and WARNINGS ). TORADOL is CONTRAINDICATED in patients with previously demonstrated hypersensitivity to ketorolac tromethamine or allergic manifestations to aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs).
The metabolic products are hydroxylated and conjugated forms of the parent drug.
OBJECTIVES AND METHODS: The bioavailability of tramadol after i.m. injection of tramadol-HCl was determined from serum concentration data in a balanced two-period crossover study with 12 healthy male subjects in comparison to the 30-min i.v. infusion. Additionally, the tramadol concentrations in saliva and urine.
Generate a file for use with external citation management software.
results for all PK parameters agreed well with those of previous studies. Retrospective sparteine phenotyping revealed two of the subjects as poor metabolizers (PM). infusion were t(max) = 0.50 (0.33, 1.50) h and c(max) = 293 (1.35) ng/ml. Thus, the results reflect the different invasion kinetics of the two modes of administration. The i.v. The 90% CI of F = AUCi.m./AUCi.v. Tramadol concentrations in saliva and urine were considerably higher than in serum.
The objective of this study was to evaluate the analgesic efficacy produced by tramadol given by two different routes of administration in patients experiencing pain Female; Humans; Injections; Injections, Intramuscular; Ketorolac/administration & dosage; Ketorolac/therapeutic use; Male; Middle Aged; Molar, Third/surgery.
Nine patients requiring additional medication were treated with ketorolac 30 mg injected intramuscularly; 2 in the systemic group, 2 in the local group, 4 in the control group and only 1 in the combination group. The duration of the anesthetic effect was significantly longer in the groups where tramadol was injected into the surgical site (215 and 252 min). A significant reduction in the consumption of ketorolac was seen in all treatments as compared to the control group. Patients were assigned into four groups of treatment, twelve subjects per group: Group A, tramadol 50 mg IM one hr before surgery; group B, tramadol 50 mg into the surgical site; group C, tramadol by both routes of administration, 50 mg IM one hr before surgery plus 50 mg into the surgical site; and group D, control.
The dogs were randomly divided into 2 groups (
Received 22 March 2012; Accepted 9 April 2012.
L. I. Academic Editors: G. Romalde, and B. Yoon. Pharr, J. T.
To receive news and publication updates for The Scientific World Journal, enter your address in the box below.
1Department of Veterinary Clinical Studies, Faculty of Veterinary Medicine, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia 2Department of Veterinary Surgery & Radiology, Faculty of Veterinary Medicine, Usmanu Danfodiyo University Sokoto, PMB 2346, Sokoto, Nigeria 3Department of Veterinary Preclinical Studies, Faculty of Veterinary Medicine, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia 4Department of Veterinary Pathology and Microbiology, Faculty of Veterinary Medicine, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia 5Human Genome Centre, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, 16150 Kubang Kerian, Malaysia.
2012 Salisu Buhari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.